These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
151 related items for PubMed ID: 11299035
1. The impact of 34 years of massive DEC chemotherapy on Wuchereria bancrofti infection and transmission: the Maupiti cohort. Esterre P, Plichart C, Sechan Y, Nguyen NL. Trop Med Int Health; 2001 Mar; 6(3):190-5. PubMed ID: 11299035 [Abstract] [Full Text] [Related]
2. Evaluation of effectiveness of diethylcarbamazine/albendazole combination in reduction of Wuchereria bancrofti infection using multiple infection parameters. Wamae CN, Njenga SM, Ngugi BM, Mbui J, Njaanake HK. Acta Trop; 2011 Sep; 120 Suppl 1():S33-8. PubMed ID: 20933491 [Abstract] [Full Text] [Related]
3. Randomised community-based trial of annual single-dose diethylcarbamazine with or without ivermectin against Wuchereria bancrofti infection in human beings and mosquitoes. Bockarie MJ, Alexander ND, Hyun P, Dimber Z, Bockarie F, Ibam E, Alpers MP, Kazura JW. Lancet; 1998 Jan 17; 351(9097):162-8. PubMed ID: 9449870 [Abstract] [Full Text] [Related]
4. Changes in Wuchereria bancrofti infection in a highly endemic community following 10 rounds of mass administration of diethylcarbamazine. Ramaiah KD, Vanamail P, Das PK. Trans R Soc Trop Med Hyg; 2007 Mar 17; 101(3):250-5. PubMed ID: 16890256 [Abstract] [Full Text] [Related]
5. Prolonged persistence of residual Wuchereria bancrofti infection after cessation of diethylcarbamazine-fortified salt programme. Ramaiah KD, Thiruvengadam B, Vanamail P, Subramanian S, Gunasekaran S, Nilamani N, Das PK. Trop Med Int Health; 2009 Aug 17; 14(8):870-6. PubMed ID: 19552662 [Abstract] [Full Text] [Related]
6. Kinetics of microfilaraemia & antigenaemia status by Og(4)C(3) ELISA in bancroftian filariasis. Malla N, Elango A, Pani SP, Mahajan RC. Indian J Med Res; 2007 Dec 17; 126(6):567-74. PubMed ID: 18219085 [Abstract] [Full Text] [Related]
7. Persistence of lymphatic filarial infection in the paediatric population of rural community, after six rounds of annual mass drug administrations. Sunish IP, Munirathinam A, Kalimuthu M, Ashok Kumar V, Tyagi BK. J Trop Pediatr; 2014 Jun 17; 60(3):245-8. PubMed ID: 24343822 [Abstract] [Full Text] [Related]
8. Towards eliminating lymphatic filariasis in Papua New Guinea: impact of annual single-dose mass treatment on transmission of Wuchereria bancrofti in East Sepik Province. Bockarie MJ, Ibam E, Alexander ND, Hyun P, Dimber Z, Bockarie F, Alpers MP, Kazura JW. P N G Med J; 2000 Jun 17; 43(3-4):172-82. PubMed ID: 11939298 [Abstract] [Full Text] [Related]
9. Cumulative mortality rates in Aedes polynesiensis after feeding on polynesian Wuchereria bancrofti carriers treated with single doses of ivermectin, diethylcarbamazine and placebo. Cartel JL, Sechan Y, Spiegel A, Nguyen L, Barbazan P, Martin PM, Roux JF. Trop Med Parasitol; 1991 Dec 17; 42(4):343-5. PubMed ID: 1796230 [Abstract] [Full Text] [Related]
11. The influence of the mass administration of diethylcarbamazine, alone or with albendazole, on the prevalence of filarial antigenaemia. Rajendran R, Sunish IP, Mani TR, Munirathinam A, Abdullah SM, Augustin DJ, Satyanarayana K. Ann Trop Med Parasitol; 2002 Sep 17; 96(6):595-602. PubMed ID: 12396322 [Abstract] [Full Text] [Related]
14. Microfilaraemia, filarial antibody, antigen and immune complex levels in human filariasis before, during and after DEC therapy. A two-year follow-up. Ramaprasad P, Prasad GB, Harinath BC. Acta Trop; 1988 Sep 17; 45(3):245-55. PubMed ID: 2903626 [Abstract] [Full Text] [Related]
16. Heterogeneous response of Wuchereria bancrofti-infected persons to diethylcarbamazine (DEC) and its implications for the Global Programme to Eliminate Lymphatic Filariasis (GPELF). Sankari T, Subramanian S, Hoti SL, Pani SP, Jambulingam P, Das PK. Parasitol Res; 2021 Jan 17; 120(1):311-319. PubMed ID: 33146778 [Abstract] [Full Text] [Related]
17. Single versus repeated doses of ivermectin and diethylcarbamazine for the treatment of Wuchereria bancrofti var. pacifica microfilaremia. Results at 12 months of a double-blind study. Cartel JL, Spiegel A, Nguyen Ngnoc L, Cardines R, Plichart R, Martin PM, Roux JF. Trop Med Parasitol; 1991 Dec 17; 42(4):335-8. PubMed ID: 1796228 [Abstract] [Full Text] [Related]
18. The epidemiology and control of lymphatic filariasis on Lihir Island, New Ireland Province. Hii J, Bockarie MJ, Flew S, Genton B, Tali A, Dagoro H, Waulas B, Samson M, Alpers MP. P N G Med J; 2000 Dec 17; 43(3-4):188-95. PubMed ID: 11939300 [Abstract] [Full Text] [Related]
19. Children and adolescents infected with Wuchereria bancrofti in Greater Recife, Brazil: a randomized, year-long clinical trial of single treatments with diethylcarbamazine or diethylcarbamazine-albendazole. Rizzo JA, Belo C, Lins R, Dreyer G. Ann Trop Med Parasitol; 2007 Jul 17; 101(5):423-33. PubMed ID: 17550648 [Abstract] [Full Text] [Related]
20. Community-based study to assess the efficacy of DEC plus ALB against DEC alone on bancroftian filarial infection in endemic areas in Tamil Nadu, south India. Rajendran R, Sunish IP, Mani TR, Munirathinam A, Arunachalam N, Satyanarayana K, Dash AP. Trop Med Int Health; 2006 Jun 17; 11(6):851-61. PubMed ID: 16772007 [Abstract] [Full Text] [Related] Page: [Next] [New Search]